These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19671143)

  • 1. Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population.
    Siedlinski M; Postma DS; Boer JM; van der Steege G; Schouten JP; Smit HA; Boezen HM
    Respir Res; 2009 Aug; 10(1):73. PubMed ID: 19671143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NFE2L2 pathway polymorphisms and lung function decline in chronic obstructive pulmonary disease.
    Sandford AJ; Malhotra D; Boezen HM; Siedlinski M; Postma DS; Wong V; Akhabir L; He JQ; Connett JE; Anthonisen NR; Paré PD; Biswal S
    Physiol Genomics; 2012 Aug; 44(15):754-63. PubMed ID: 22693272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NFE2L2 polymorphisms, mortality, and metabolism in the general population.
    Figarska SM; Vonk JM; Boezen HM
    Physiol Genomics; 2014 Jun; 46(12):411-7. PubMed ID: 24790085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of KEAP1 and NFE2L2 polymorphisms with temporal lobe epilepsy and drug resistant epilepsy.
    Liu Z; Yin X; Liu L; Tao H; Zhou H; Ma G; Cui L; Li Y; Zhang S; Xu Z; Yao L; Cai Z; Zhao B; Li K
    Gene; 2015 Oct; 571(2):231-6. PubMed ID: 26149655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of the NRF2/KEAP1 pathway and antioxidant defense gene polymorphisms with chronic obstructive pulmonary disease.
    Korytina GF; Akhmadishina LZ; Aznabaeva YG; Kochetova OV; Zagidullin NS; Kzhyshkowska JG; Zagidullin SZ; Viktorova TV
    Gene; 2019 Apr; 692():102-112. PubMed ID: 30641209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of NFE2L2 and KEAP1 haplotypes with amyotrophic lateral sclerosis.
    Bergström P; von Otter M; Nilsson S; Nilsson AC; Nilsson M; Andersen PM; Hammarsten O; Zetterberg H
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):130-7. PubMed ID: 24102512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCC1 polymorphisms contribute to level and decline of lung function in two population-based cohorts.
    Siedlinski M; Boezen HM; Boer JM; Smit HA; Postma DS
    Pharmacogenet Genomics; 2009 Sep; 19(9):675-84. PubMed ID: 19687781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KEAP1 polymorphisms and neurodevelopmental outcomes in children with exposure to prenatal MeHg from the Seychelles Child Development Study Nutrition Cohort 2.
    de Paula HK; Love TM; Pineda D; Watson GE; Thurston SW; Yeates AJ; Mulhern MS; McSorley EM; Strain JJ; Shamlaye CF; Myers GJ; Rand MD; van Wijngaarden E; Broberg K
    Neurotoxicology; 2023 Dec; 99():177-183. PubMed ID: 37858899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes.
    Hartikainen JM; Tengström M; Winqvist R; Jukkola-Vuorinen A; Pylkäs K; Kosma VM; Soini Y; Mannermaa A
    Clin Cancer Res; 2015 Apr; 21(7):1591-601. PubMed ID: 25589623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decorin and TGF-beta1 polymorphisms and development of COPD in a general population.
    van Diemen CC; Postma DS; Vonk JM; Bruinenberg M; Nolte IM; Boezen HM
    Respir Res; 2006 Jun; 7(1):89. PubMed ID: 16780585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma.
    Goeman F; De Nicola F; Scalera S; Sperati F; Gallo E; Ciuffreda L; Pallocca M; Pizzuti L; Krasniqi E; Barchiesi G; Vici P; Barba M; Buglioni S; Casini B; Visca P; Pescarmona E; Mazzotta M; De Maria R; Fanciulli M; Ciliberto G; Maugeri-Saccà M
    J Thorac Oncol; 2019 Nov; 14(11):1924-1934. PubMed ID: 31323387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variations and haplotype structures of transcriptional factor Nrf2 and its cytosolic reservoir protein Keap1 in Japanese.
    Fukushima-Uesaka H; Saito Y; Maekawa K; Kamatani N; Kajio H; Kuzuya N; Noda M; Yasuda K; Sawada J
    Drug Metab Pharmacokinet; 2007 Jun; 22(3):212-9. PubMed ID: 17603223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact on the Clinical Evolution of Patients with COVID-19 Pneumonia and the Participation of the
    Soto ME; Fuentevilla-Álvarez G; Palacios-Chavarría A; Vázquez RRV; Herrera-Bello H; Moreno-Castañeda L; Torres-Paz YE; González-Moyotl NJ; Pérez-Torres I; Aisa-Alvarez A; Manzano-Pech L; Pérez-Torres I; Huesca-Gómez C; Gamboa R
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
    von Otter M; Landgren S; Nilsson S; Celojevic D; Bergström P; Håkansson A; Nissbrandt H; Drozdzik M; Bialecka M; Kurzawski M; Blennow K; Nilsson M; Hammarsten O; Zetterberg H
    BMC Med Genet; 2010 Mar; 11():36. PubMed ID: 20196834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in TIMP1 but not MMPs predict excess FEV1 decline in two general population-based cohorts.
    van Diemen CC; Postma DS; Siedlinski M; Blokstra A; Smit HA; Boezen HM
    Respir Res; 2011 Apr; 12(1):57. PubMed ID: 21524282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary factors and lung function in the general population: wine and resveratrol intake.
    Siedlinski M; Boer JM; Smit HA; Postma DS; Boezen HM
    Eur Respir J; 2012 Feb; 39(2):385-91. PubMed ID: 21852339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Pathological Characteristics of
    Frank R; Scheffler M; Merkelbach-Bruse S; Ihle MA; Kron A; Rauer M; Ueckeroth F; König K; Michels S; Fischer R; Eisert A; Fassunke J; Heydt C; Serke M; Ko YD; Gerigk U; Geist T; Kaminsky B; Heukamp LC; Clement-Ziza M; Büttner R; Wolf J
    Clin Cancer Res; 2018 Jul; 24(13):3087-3096. PubMed ID: 29615460
    [No Abstract]   [Full Text] [Related]  

  • 18. Glutathione S-transferase genotypes modify lung function decline in the general population: SAPALDIA cohort study.
    Imboden M; Downs SH; Senn O; Matyas G; Brändli O; Russi EW; Schindler C; Ackermann-Liebrich U; Berger W; Probst-Hensch NM;
    Respir Res; 2007 Jan; 8(1):2. PubMed ID: 17217536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in signal transducer and activator of transcription 3 and lung function in asthma.
    Litonjua AA; Tantisira KG; Lake S; Lazarus R; Richter BG; Gabriel S; Silverman ES; Weiss ST
    Respir Res; 2005 Jun; 6(1):52. PubMed ID: 15935090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity.
    Lee DH; Park JS; Lee YS; Han J; Lee DK; Kwon SW; Han DH; Lee YH; Bae SH
    Autophagy; 2020 Nov; 16(11):1949-1973. PubMed ID: 31913745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.